Hamdy F - Search Results

1

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Cappuccini F, Bryant R, Pollock E, Carter L, Verrill C, Hollidge J, Poulton I, Baker M, Mitton C, Baines A, Meier A, Schmidt G, Harrop R, Protheroe A, MacPherson R, Kennish S, Morgan S, Vigano S, Romero PJ, Evans T, Catto J, Hamdy F, Hill AVS, Redchenko I. Cappuccini F, et al. Among authors: hamdy f. J Immunother Cancer. 2020 Jun;8(1):e000928. doi: 10.1136/jitc-2020-000928. J Immunother Cancer. 2020. PMID: 32591433 Free PMC article. Clinical Trial.

2

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.

Catto JW, Xinarianos G, Burton JL, Meuth M, Hamdy FC. Catto JW, et al. Among authors: hamdy fc. Int J Cancer. 2003 Jul 1;105(4):484-90. doi: 10.1002/ijc.11109. Int J Cancer. 2003. PMID: 12712438

3

Early diagnosis and surgical management of prostate cancer.

Linton KD, Hamdy FC. Linton KD, et al. Cancer Treat Rev. 2003 Jun;29(3):151-60. doi: 10.1016/s0305-7372(03)00096-3. Cancer Treat Rev. 2003. PMID: 12787710 Review.

4

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.

Catto JW, Linkens DA, Abbod MF, Chen M, Burton JL, Feeley KM, Hamdy FC. Catto JW, et al. Among authors: hamdy fc. Clin Cancer Res. 2003 Sep 15;9(11):4172-7. Clin Cancer Res. 2003. PMID: 14519642

5

Less is more: artificial intelligence and gene-expression arrays.

Hamdy FC, Catto JW. Hamdy FC, et al. Lancet. 2004 Dec 4-10;364(9450):2003-4. doi: 10.1016/S0140-6736(04)17528-4. Lancet. 2004. PMID: 15582046 No abstract available.

6

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.

Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J, Hamdy FC. Rehman I, et al. Among authors: hamdy fc. Hum Pathol. 2004 Nov;35(11):1385-91. doi: 10.1016/j.humpath.2004.07.015. Hum Pathol. 2004. PMID: 15668896

7

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.

Rehman I, Cross SS, Catto JW, Leiblich A, Mukherjee A, Azzouzi AR, Leung HY, Hamdy FC. Rehman I, et al. Among authors: hamdy fc. Prostate. 2005 Dec 1;65(4):322-30. doi: 10.1002/pros.20302. Prostate. 2005. PMID: 16015609

8

Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression.

Catto JW, Abbod MF, Linkens DA, Hamdy FC. Catto JW, et al. Among authors: hamdy fc. J Urol. 2006 Feb;175(2):474-9. doi: 10.1016/S0022-5347(05)00246-6. J Urol. 2006. PMID: 16406976

9

Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.

Catto JW, Hartmann A, Stoehr R, Bolderson E, Rehman I, Rosario DJ, Hamdy FC, Meuth M. Catto JW, et al. Among authors: hamdy fc. J Urol. 2006 Jun;175(6):2323-30. doi: 10.1016/S0022-5347(06)00256-4. J Urol. 2006. PMID: 16697867

10

DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer.

Rehman I, Goodarzi A, Cross SS, Leiblich A, Catto JW, Phillips JT, Hamdy FC. Rehman I, et al. Among authors: hamdy fc. Prostate. 2007 Mar 1;67(4):341-7. doi: 10.1002/pros.20401. Prostate. 2007. PMID: 17219414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters